Khaberni - A preliminary study to be presented in the scientific sessions of the American Heart Association in 2025 next Friday has indicated that individuals with type 2 diabetes at high risk of cardiovascular disease, who took a low dose of aspirin, were less likely to suffer from a serious heart attack, including heart attacks or strokes or death.
The study included health records for more than 11,000 patients with type 2 diabetes, who have a medium or high-risk score for heart disease.
Large Scale of Protection
The research team from the University of Pittsburgh was surprised by the large extent of protection provided by the low dose of aspirin against heart attacks in diabetic patients, despite recent studies not proving the benefit of aspirin in primary prevention among people without cardiovascular disease.
According to "Medical Express", the analysis concluded the following:
• Adults with type 2 diabetes, who took a low dose of aspirin, were less likely to suffer from a heart attack (42.4%) compared to those who did not take a low dose of aspirin (61.2%).
Stroke and Risk of Death
• The risk of having a stroke was also lower for diabetic patients who took a low dose of aspirin (14.5%), compared to 24.8% among those who did not take aspirin.
• Additionally, the risk of death from any cause over 10 years decreased (33% in the aspirin group versus 50.7% in the non-aspirin group).
• Any low usage of aspirin doses among the participants was associated with a decreased risk of heart attacks and strokes, with the greatest benefit observed among those who frequently took low doses of aspirin.
